Internal Medicine
Home Internal Medicine
Anticoagulation May Improve Outcomes in COVID-19 Patients
Longer duration of AC treatment linked to reduced risk for mortality in hospitalized patients
GI Symptoms Seen in Less Than 10 Percent of COVID-19 Patients
Outpatients with new-onset GI symptoms should be monitored for COVID-19 symptoms
Health Insurance Coverage Disruption Impedes Cancer Care
Findings consistent across cancer continuum, from screening to treatment and end-of-life care
HIV+ Men Are Not Receiving STD Testing, Prevention Services
Men receiving HIV care still not receiving guideline-recommended sexually transmitted disease testing
ACE Inhibitors, ARBs Not Linked to In-Hospital COVID-19 Death
Risk for in-hospital death increased with age >65, underlying cardiovascular disease, COPD, smoking
Guideline Issued for Nonsevere, Severe COVID-19 Therapy
Corticosteroids recommended for severe COVID-19 with ARDS but not severe COVID-19 without ARDS
High Clinical Burden Associated With Nonalcoholic Fatty Liver Disease
Prevalence of NAFLD was 5.7 percent, with cumulative risk for mortality of 12.6 percent for NAFLD
Well-Controlled Blood Glucose May Improve COVID-19 Outcomes
Mortality lower in hospitalized COVID-19 patients with T2DM who had well-controlled blood glucose
Human Trials of Experimental COVID-19 Vaccine Begin in U.S.
If effective, vaccine could be available for emergency use in the United States as early as September
Health Care Workers at Risk From Mental Burden of COVID-19
Prevalence of anxiety symptoms higher for health care workers/young spending more time on outbreak
